Along this line, we recently showed that chronic HCV infected individuals with cirrhosis displayed a greater magnitude of naïve CD4+ lymphopenia and effector/memory CD4+ and CD8+ Tell activation when compared to their non-cirrhotic counterparts even after effective DAA therapy [24,25]. This evidence concerns the gene CD4 and Cirrhosis.